NCT04184921 2026-02-03
Combination of Osimertinib and Aspirin to Treat EGFR Mutation NSCLC Patients
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Phase 2 Completed
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano